Primary Crystallization’s Influence on Fluticasone DPIs
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Discover the impact of crystallization on mechanical properties & secondary processing of Fluticasone Propionate in dry powder inhaler formulations.
Assessing Particle Size in DPIs with Spraytec & Unidose
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Assess setups to combine Spraytec & Unidose™ for evaluating particle size distribution in dry powder inhalers.
Pulmonary Fate of Fluticasone: Challenges Met
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Nanopharm investigate the pulmonary effect of Fluticasone and related compounds, addressing physiologic and pharmacokinetic challenges.
Regional Deposition in Generic Dry Powder Inhalers
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Nanopharm investigate regional deposition and simulated inhaled pharmacokinetic profiles of generic dry powder inhalers.
Mixed Kinetic Model of Inhaled Corticosteroid Dissolution
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Explore the dissolution kinetics of inhaled pharmaceuticals in dry powder inhalers (DPI) and pressurized metered dose inhalers (pMDI).
Automated Classification of DPI Agglomerate Particles
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Explore automated classification of dry powder inhaler particles using Cluster Analysis and Morphologically Directed Raman Spectroscopy.